Published in Medical Letter on the CDC and FDA, March 30th, 2003
Because patients with thalassemia require frequent blood transfusions, an important thrust of the grant will be to monitor the nation's blood supply for new infectious agents.
The principal investigator of the grant is Alan R. Cohen, MD, director of Children's Hospital's Thalassemia Program. A pediatric hematologist, Cohen is physician-in-chief at the Children's Hospital of Philadelphia, and a world-renowned...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA